Follow-Up of Adverse Drug Reactions from Peginterferon Alfa-2b—Ribavirin Therapy
October 2004
in “
Pharmacotherapy
”
Studysummary In this study, peginterferon alfa-2b plus ribavirin therapy in hepatitis C patients was associated with serious adverse drug reactions in 20% of cases, highlighting differences from clinical trial findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on accpjournals.onlinelibrary.wiley.com →